Skip to search boxSkip to navigationSkip to main content

Prebiotics and probiotics as potential therapy for cognitive impairment

Research Output: Contribution to journal Article Peer-review

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Article number

109410

Journal (Volume, Issue Number)

Medical Hypotheses (Volume 134)

Publication milestones

  • Published - 01/01/2020

Publication status

Published - 01/01/2020

ISSN

0306-9877

Publication IDs

  • Scopus: 85073258494
  • PubMed: 31627123

Abstract

Cognitive functions, such as learning and memory, may be impaired during aging. Age-related cognitive impairment is associated with selective neuronal loss, oxidative changes that lead to microglia activation and neuroinflammation. In addition, it is associated to alteration reduction in trophic factors affecting neurogenesis and synaptic plasticity. In recent years, attention has been paid to the relationship between gut microbiota and brain. In aging, there is an alteration in microbiota, gut microbiota diversity is perturbed with an increase in pathogenic bacteria at the expense of beneficial ones. Dysbiosis may lead to chronic inflammation, and a decrease in bacteria metabolites such as short-chain fatty acids which have been related to an upregulation of neurotrophic factors. Supplementation with prebiotics and probiotics can modulate gut microbiota, returning it to a more physiological state; thus, they may be considered as a possible treatment for age-related cognitive impairment.

Publication metrics

Metrics

SciVal
FWCI
1.50

PlumX, opens in new tab

Captures
164
Social media
43
41